Kathmandu, Nepal, April 10, 2014: Three candidates- Umesh Lal Shrestha, founder and managing director of Quest Pharmaceutical, Anjan Shrestha, executive director at Laxmi Group and Ram Chandra Sanghai of the Triveni Group are competing for the v
OncoQuest Pharmaceuticals Inc Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Share this article
TSX Venture: QPT
EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ( Quest or the Company ) announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ( OQP ) lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) conference proceedings. OQP acquired oregovomab from OncoQuest Inc., one of the equity investee companies (45%) of Quest PharmaTech Inc.
The first presentation by Dr. Angeles Alvarez Secord, Principal Investigator and Associate Director of Clinical Research at Duke Cancer Institute of Duke University will update the research community on progress with the ongoing FLORA 5 phase III clinical study of front-line carboplatin-paclitaxel-oregovomab chemotherapy. This double blind and placebo con
Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc and OncoQuest Pharmaceuticals Inc newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.